Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Pain 14Multiple Myeloma 12Pain, Postoperative 10Neoplasms 9Agnosia 8Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Cancer Pain 5Breast Neoplasms 5Neoplasm Metastasis 4Lymphoma 4Leukemia 4Hodgkin Disease 4Head and Neck Neoplasms 4Burkitt Lymphoma 4Prostatic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Lymphoma, B-Cell 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Hairy Cell 3Hematologic Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Trigger Finger Disorder 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Myelodysplastic Syndromes 2Melanoma 2Lymphoma, Mantle-Cell 2

Interventions

Fluorouracil 498Bevacizumab 476Oxaliplatin 450Leucovorin 442Irinotecan 408Cetuximab 318Capecitabine 317pembrolizumab 142Folfox protocol 128Panitumumab 117regorafenib 105Colonoscopy 88Nivolumab 82IFL protocol 81Drug Therapy 77trifluridine tipiracil drug combination 73Radiotherapy 66HMPL-013 65Blood Specimen Collection 52Gemcitabine 49Specimen Handling 47Standard of Care 45Neoadjuvant Therapy 45Magnetic Resonance Spectroscopy 44Biopsy 44Chemotherapy, Adjuvant 41Trifluridine 40atezolizumab 39Cyclophosphamide 39Surveys and Questionnaires 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Acetaminophen × Clear all
NCT01607905 2023-01-26

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Karyopharm Therapeutics Inc

Phase 1 Completed
192 enrolled 29 charts
CNSDermatologicGastrointestinal

Adenocarcinoma, Carcinoma, Squamous Cell, Glioblastoma, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡